Imaging Techniques for the Assessment of Myocardial Perfusion

1. Remme WJ, Swedberg K, Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001;22:1527-1560.10.1053/euhj.2001.2783Search in Google Scholar

2. Mock MB, Ringqvist I, Fisher LD, et al. Survival of medically treated patients in the Coronary Artery Surgery Study (CASS). Circulation. 1982;66:562-568.10.1161/01.CIR.66.3.562Search in Google Scholar

3. Opie LH. The ever expanding spectrum of ischemic left ventricular dysfunction. Cardiovasc Drugs Ther. 1994;8(Suppl2):297-304.10.1007/BF00877313Search in Google Scholar

4. Brauwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.10.1161/01.CIR.66.6.1146Search in Google Scholar

5. Nesto RW, Kowalchuk GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol. 1987;59:23C-30C.10.1016/0002-9149(87)90192-5Search in Google Scholar

6. Salerno M, Beller GA. Noninvasive Assessment of Myocardial Perfusion. Circ Cardiovasc Imaging. 2009;2:412-424.10.1161/CIRCIMAGING.109.854893Search in Google Scholar

7. Geleijnse ML, Fioretti PM, Roelandt JR. Methodology, feasibility, safety, and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol. 1997;30:595-606.10.1016/S0735-1097(97)00206-4Search in Google Scholar

8. Marwick TH. Current status of stress echocardiography for diagnosis and prognostic assessment of coronary artery disease. Coron Artery Dis. 1998;9:411-426.10.1097/00019501-199809070-000049822860Search in Google Scholar

9. Schwitter J, Wacker CM, Wilke N, et al. MR-IMPACT II: magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. Eur Heart J. 2013;34:775-781.10.1093/eurheartj/ehs02222390914Search in Google Scholar

10. Camici PG, Prasad SK, Rimoldi OE. Stunning, Hibernation, and Assessment of Myocardial Viability. Circulation. 2008;117:103-114.10.1161/CIRCULATIONAHA.107.70299318172050Search in Google Scholar

11. Haas F, Haehnel CJ, Picker W, et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol. 1997;30:1693-1700.10.1016/S0735-1097(97)00375-6Search in Google Scholar

12. Chatterjee K, Swan HJ, Parmley WW, Sustaita H, Marcus HS, Matloff J. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction. Circulation. 1973;47:276-286.10.1161/01.CIR.47.2.276Search in Google Scholar

13. Schulz R, Heusch G. Hibernating myocardium. Heart. 2000;84:587-594.10.1136/heart.84.6.587Search in Google Scholar

14. Bolli R. Myocardial ‘stunning’ in man. Circulation. 1992;86:1671.10.1161/01.CIR.86.6.1671Search in Google Scholar

15. Barnes E, Dutka DP, Khan M, Camici PG, Hall RJ. Effect of repeated episodes of reversible myocardial ischemia on myocardial blood flow and function in humans. Am J Physiol Heart Circ Physiol. 2002;282:H1603-H1608.10.1152/ajpheart.00786.2001Search in Google Scholar

16. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:617-626.10.1016/0735-1097(94)90745-5Search in Google Scholar

17. Marwick T, D’Hondt A-M, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol. 1993;22:159-167.Search in Google Scholar

18. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularisation in patients with ischaemic congestive heart failure. J Am Coll Cardiol. 1999;33:1848-1854.10.1016/S0735-1097(99)00102-3Search in Google Scholar

19. Kaul S. Assessment of coronary microcirculation with myocardial contrast echocardiography: current and future clinical applications. Br Heart J. 1995;74:490-495.10.1136/hrt.73.6.4904839067626344Search in Google Scholar

20. Wei K, Jayaweera AR, Firoozan S, et al. Ultrasound induced microbubble destruction during venous infusion: a novel method in Imaging techniques for the assessment of myocardial hibernation of myocardial blood flow with echocardiography. Circulation. 1998;97:473-483.10.1161/01.CIR.97.5.4739490243Search in Google Scholar

21. Meza MF, Ramee S, Collins T, et al. Knowledge of perfusion and contractile reserve improves the predictive value of recovery of regional myocardial function postrevascularization: a study using the combination of myocardial contrast echocardiography and dobutamine echocardiography. Circulation. 1997;96:3459-3465.10.1161/01.CIR.96.10.3459Search in Google Scholar

22. Ragosta M, Camarano G, Kaul S, Powers ER, Sarembok IJ, Gimple LV. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: new insights using myocardial contrast echocardiography. Circulation. 1994;89:2562-2569.10.1161/01.CIR.89.6.25628205665Search in Google Scholar

23. Picano E, Sicari R, Landi P, et al. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation. 1998;98:1078-1084.10.1161/01.CIR.98.11.1078Search in Google Scholar

24. Sutherland GR, Stewart MJ, Groundstroem KWE, et al. Color Doppler Myocardial Imaging: A New Technique for the Assessment of Myocardial function. Journal of the American Society of Echocardiography. 1994;29:A1-A28.Search in Google Scholar

25. Di Carli MF, Hachamovitch R. Should PET replace SPECT for evaluating CAD? The end of the beginning. J Nucl Cardiol. 2006;13:2-7.10.1016/j.nuclcard.2005.12.00116464710Search in Google Scholar

26. Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes. 2002;51:3020-3024.10.2337/diabetes.51.10.302012351442Search in Google Scholar

27. Auerbach MA, Schoder H, Hoh C, et al. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation. 1999;99:2921-2926.10.1161/01.CIR.99.22.2921Search in Google Scholar

28. Marshall RC, Tillisch JH, Phelps ME, et al. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18-F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation. 1983;67:766-788.10.1161/01.CIR.67.4.766Search in Google Scholar

29. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron emission tomography. N Engl J Med. 1986;314:884-888.10.1056/NEJM1986040331414053485252Search in Google Scholar

30. Bateman TM, Heller GV, McGhie AI, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol. 2006;13:24-33.10.1016/j.nuclcard.2005.12.00416464714Search in Google Scholar

31. Knaapen P, de Haan S, Hoekstra OS, et al. Cardiac PET-CT: advanced hybrid imaging for the detection of coronary artery disease. Netherlands Heart Journal. 2010;18:90-98.10.1007/BF03091744282856920200615Search in Google Scholar

32. Sogbein OO, Pelletier-Galarneau M, Schindler TH, Wei L, Wells RG, Ruddy TD. New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease. Biomed Res Int. 2014; 2014:94296033.10.1155/2014/942960403465724901002Search in Google Scholar

33. Mori T, Minamiji K, Kurogane H, et al. Rest injected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med. 1991;32:1718-1724.Search in Google Scholar

34. Berman DS, Kang X, Slomka PJ, et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol. 2007;14:521-528.10.1016/j.nuclcard.2007.05.00817679060Search in Google Scholar

35. Stabin MG. Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk. J Nucl Med. 2008;49:1555-1563.10.2967/jnumed.108.05224118765586Search in Google Scholar

36. Hamirani YS, Kramer CM. Cardiac MRI assessment of myocardial perfusion. Future cardiology. 2014;10:349-358.10.2217/fca.14.18415277324976472Search in Google Scholar

37. Gerber BL, Raman SV, Nayak K, et al. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. Journal of Cardiovascular Magnetic Resonance. 2008;10:18.10.1186/1532-429X-10-18238715518442372Search in Google Scholar

38. Nandalur KR, Dwamena BA, Choudri AF, et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2007;50:1343-1353.10.1016/j.jacc.2007.06.03017903634Search in Google Scholar

39. Morton G, Ishida M, Schuster A, et al. Perfusion cardiovascular magnetic resonance: comparison of an advanced, high resolution and a standard sequence. Journal of Cardiovascular Magnetic Resonance. 2012;9:34.10.1186/1532-429X-14-34340396222682016Search in Google Scholar